Does NADOLOL Cause Therapeutic product effect incomplete? 251 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 251 reports of Therapeutic product effect incomplete have been filed in association with NADOLOL (Nadolol). This represents 13.4% of all adverse event reports for NADOLOL.
251
Reports of Therapeutic product effect incomplete with NADOLOL
13.4%
of all NADOLOL reports
0
Deaths
246
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From NADOLOL?
Of the 251 reports, 246 (98.0%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADOLOL. However, 251 reports have been filed with the FAERS database.
What Other Side Effects Does NADOLOL Cause?
Drug ineffective (989)
Macular degeneration (781)
Off label use (330)
Weight decreased (324)
Nausea (295)
Dyspepsia (263)
Abdominal pain (259)
Pain (244)
Malaise (241)
Chronic sinusitis (237)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which NADOLOL Alternatives Have Lower Therapeutic product effect incomplete Risk?
NADOLOL vs NADROPARIN
NADOLOL vs NAFARELIN
NADOLOL vs NAFCILLIN
NADOLOL vs NAFCILLIN\NAFCILLIN
NADOLOL vs NAFRONYL